Complex association analysis of Graves disease using a set of polymorphic markers

被引:55
作者
Chistyakov, DA
Savost'anov, KV
Turakulov, RI
Petunina, NA
Trukhina, LV
Kudinova, AV
Balabolkin, MI
Nosikov, VV
机构
[1] State Res Ctr GosNIIgenet, Dept Mol Diagnost, Moscow 113545, Russia
[2] Endocrinol Res Ctr, Moscow 117036, Russia
[3] IM Sechenov Med Acad, Dept Endocrinol & Diabetol, Moscow 119435, Russia
关键词
CTLA4; LMP2; TSHR; IL1RN; association; Graves disease;
D O I
10.1006/mgme.2000.3007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves disease is complex autoimmune thyrotoxicosis. A number of genes may contribute to the development of the disorder. Some of them may be genes that encode cytotoxic T-lymphocyte-associated serine esterase-4 (CTLA4), subunit 2 of large multifunctional protease (LMP2), thyroid-stimulating hormone receptor (TSHR), and interleukin 1 receptor antagonist (IL1RN). We studied polymorphism of Ala17Thr CTLA4, H60R LMP2, Pro52Thr TSHR, and IL1RN-VNTR in healthy controls (n = 93) and patients with Graves disease (n = 78) using PCR. To study CTLA4, H60R, and TSHR polymorphism, PCR products were digested with MboI, Hin6I and PsyI, respectively. Comparative analysis using chi(2) test showed significant differences in allele and genotype frequency of Ala17Thr polymorphic marker between the two groups studied. Thus, the CTLA4 gene may be involved in the pathogenesis of Graves disease in a Moscow population. (C) 2000 Academic Press.
引用
收藏
页码:214 / 218
页数:5
相关论文
共 29 条
  • [1] Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves disease and Hashimoto's thyroiditis) in the Japanese population
    Awata, T
    Kurihara, S
    Iitaka, M
    Takei, S
    Inoue, I
    Ishii, C
    Negishi, K
    Izumida, T
    Yoshida, Y
    Hagura, R
    Kuzuya, N
    Kanazawa, Y
    Katayama, S
    [J]. DIABETES, 1998, 47 (01) : 128 - 129
  • [2] ASSOCIATION OF GRAVES-DISEASE WITH AN ALLELE OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE
    BLAKEMORE, AIF
    WATSON, PF
    WEETMAN, AP
    DUFF, GW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (01) : 111 - 115
  • [3] INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AS A DISEASE SEVERITY FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BLAKEMORE, AIF
    TARLOW, JK
    CORK, MJ
    GORDON, C
    EMERY, P
    DUFF, GW
    [J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (09): : 1380 - 1385
  • [4] BUDOWLE B, 1990, Applied and Theoretical Electrophoresis, V1, P181
  • [5] Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population
    Cuddihy, RM
    Bahn, RS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) : 4476 - 4478
  • [6] DENG GY, 1995, AM J HUM GENET, V56, P528
  • [7] Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease
    deRoux, N
    Shields, DC
    Misrahi, M
    Ratanachaiyavong, S
    McGregor, AM
    Milgrom, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3483 - 3486
  • [8] No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM
    Djilali-Saiah, I
    Larger, E
    Harfouch-Hammoud, E
    Timsit, J
    Clerc, J
    Bertin, E
    Assan, R
    Boitard, C
    Bach, JF
    Caillat-Zucman, S
    [J]. DIABETES, 1998, 47 (01) : 125 - 127
  • [9] CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus
    Donner, H
    Rau, H
    Walfish, PG
    Braun, J
    Siegmund, T
    Finke, R
    Herwig, J
    Usadel, KH
    Badenhoop, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) : 143 - 146
  • [10] Comparison of two polymorphisms of the interleukin-1 gene family:: Inteuleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis
    Fang, XM
    Schröder, S
    Hoeft, A
    Stüber, F
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (07) : 1330 - 1334